Management of High-Grade Prostatic Intraepithelial Neoplasia (HGPIN)

[1]  M. Gleave,et al.  Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  S. Taneja,et al.  Long-term follow-up of men with isolated high-grade prostatic intra-epithelial neoplasia followed by serial delayed interval biopsy. , 2011, Urology.

[3]  F. Montorsi,et al.  Diagnosis of high-grade prostatic intraepithelial neoplasia: the impact of the number of biopsy cores at initial sampling on cancer detection after a saturation re-biopsy. , 2010, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

[4]  M. Kattan,et al.  Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer. , 2010, The Journal of urology.

[5]  T. H. van der Kwast,et al.  Detection rates of cancer, high grade PIN and atypical lesions suspicious for cancer in the European Randomized Study of Screening for Prostate Cancer. , 2010, European journal of cancer.

[6]  J. Srigley,et al.  Is high grade prostatic intraepithelial neoplasia still a risk factor for adenocarcinoma in the era of extended biopsy sampling? , 2010, Pathology.

[7]  G. Zeng,et al.  Increased serum level of early prostate cancer antigen is associated with subsequent cancer risk in men with high-grade prostatic intraepithelial neoplasia. , 2010, Endocrine-related cancer.

[8]  D. Tindall,et al.  Effect of dutasteride on the risk of prostate cancer. , 2010, The New England journal of medicine.

[9]  R. Shah,et al.  Atypical Cribriform Lesions of the Prostate: Relationship to Prostatic Carcinoma and Implication for Diagnosis in Prostate Biopsies , 2010, The American journal of surgical pathology.

[10]  D. Bostwick,et al.  HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA AND ATYPICAL SMALL ACINAR PROLIFERATION ARE SIGNIFICANT CANCER RISK FACTORS: FOLLOW-UP STUDY OF 1,476 CASES , 2009 .

[11]  R. Miano,et al.  The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy. , 2009, The Journal of urology.

[12]  E. Venturino,et al.  Prognostic significance of high-grade prostatic intraepithelial neoplasia (HGPIN): risk of prostatic cancer on repeat biopsies. , 2008, Urology.

[13]  M. Loda,et al.  Characterization of TMPRSS2-ERG Fusion High-Grade Prostatic Intraepithelial Neoplasia and Potential Clinical Implications , 2008, Clinical Cancer Research.

[14]  S. Taneja.  BASELINE CHARACTERISTICS VALIDATE THE INCLUSION CRITERIA OF A PHASE III COMPARISON OF TOREMIFENE AND PLACEBO FOR THE PREVENTION OF PROSTATE CANCER IN MEN WITH ISOLATED HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA (HGPIN) , 2008 .

[15]  S. Taneja,et al.  Contemporary clinical management of isolated high-grade prostatic intraepithelial neoplasia , 2008, Prostate Cancer and Prostatic Diseases.

[16]  I. Thompson,et al.  Finasteride decreases the risk of prostatic intraepithelial neoplasia. , 2007, The Journal of urology.

[17]  J. Nelson,et al.  The proportion of cores with high‐grade prostatic intraepithelial neoplasia on extended‐pattern needle biopsy is significantly associated with prostate cancer on site‐directed repeat biopsy , 2007, BJU international.

[18]  C. Magi-Galluzzi,et al.  The incidence of high‐grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first‐time saturation needle biopsy, and the subsequent risk of cancer , 2007, BJU international.

[19]  W. Catalona,et al.  Use of prostate-specific antigen velocity to follow up patients with isolated high-grade prostatic intraepithelial neoplasia on prostate biopsy. , 2007, Urology.

[20]  D. Bostwick,et al.  Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial. , 2006, The Journal of urology.

[21]  J. Epstein,et al.  Widespread High-grade Prostatic Intraepithelial Neoplasia on Prostatic Needle Biopsy: A Significant Likelihood of Subsequently Diagnosed Adenocarcinoma , 2006, The American journal of surgical pathology.

[22]  J. Epstein,et al.  Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. , 2006, The Journal of urology.

[23]  S. Taneja,et al.  Toremifene – a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapy , 2006, Expert opinion on investigational drugs.

[24]  J. Epstein,et al.  Risk of prostate cancer on first re-biopsy within 1 year following a diagnosis of high grade prostatic intraepithelial neoplasia is related to the number of cores sampled. , 2006, The Journal of urology.

[25]  J. Epstein,et al.  523: Risk of Prostate Cancer on Re-Biopsy Following a Diagnosis of High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) is Related to the Number of Cores Sampled , 2005 .

[26]  P. Humphrey,et al.  High-grade prostatic intraepithelial neoplasia in needle biopsy as risk factor for detection of adenocarcinoma: current level of risk in screening population. , 2005, Urology.

[27]  M. Abdel‐Khalek,et al.  Predictors of prostate cancer on extended biopsy in patients with high‐grade prostatic intraepithelial neoplasia: a multivariate analysis model , 2004, BJU international.

[28]  Francesco Montorsi,et al.  Monofocal and plurifocal high-grade prostatic intraepithelial neoplasia on extended prostate biopsies: factors predicting cancer detection on extended repeat biopsy. , 2004, Urology.

[29]  J. Epstein,et al.  High-grade Prostatic Intraepithelial Neoplasia on Needle Biopsy: Risk of Cancer on Repeat Biopsy Related to Number of Involved Cores and Morphologic Pattern , 2004, The American journal of surgical pathology.

[30]  D. Landsittel,et al.  Early identification of individuals with prostate cancer in negative biopsies. , 2004, The Journal of urology.

[31]  P. Tamboli,et al.  Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy? , 2004, Urology.

[32]  D. Bostwick,et al.  High-grade prostatic intraepithelial neoplasia , 2004, Modern Pathology.

[33]  S. Ho.  Estrogens and anti‐estrogens: Key mediators of prostate carcinogenesis and new therapeutic candidates , 2004, Journal of cellular biochemistry.

[34]  F. Montorsi,et al.  260 Isolated mono- and pluri-focal high grade prostatic intraepithelial neoplasia (HGPIN) on initial extended prostate needle biopsies: factors predicting cancer detection on extended re-biopsy , 2004 .

[35]  Michael M Lieber,et al.  The influence of finasteride on the development of prostate cancer. , 2003, The New England journal of medicine.

[36]  J. J. Bianco,et al.  Oestrogens and prostate cancer. , 2003, Endocrine-related cancer.

[37]  J. Melamed,et al.  Followup interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate specific antigen levels. , 2002, The Journal of urology.

[38]  Ximing J. Yang,et al.  Prevalence of high-grade prostatic intraepithelial neoplasia and its relationship to serum prostate specific antigen. , 2002, International braz j urol : official journal of the Brazilian Society of Urology.

[39]  S. Taneja,et al.  Is repeat prostate biopsy for high-grade prostatic intraepithelial neoplasia necessary after routine 12-core sampling? , 2001, Urology.

[40]  J. Roberts,et al.  Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy. , 2001, The Journal of urology.

[41]  Jonathan I. Epstein,et al.  Predicting Cancer Following a Diagnosis of High-Grade Prostatic Intraepithelial Neoplasia on Needle Biopsy: Data on Men With More Than One Follow-Up Biopsy , 2001, The American journal of surgical pathology.

[42]  I. Leav,et al.  Comparative Studies of the Estrogen Receptors β and α and the Androgen Receptor in Normal Human Prostate Glands, Dysplasia, and in Primary and Metastatic Carcinoma , 2001 .

[43]  C. Brendler,et al.  High-grade prostatic intraepithelial neoplasia with adjacent atypia is associated with a higher incidence of cancer on subsequent needle biopsy than high-grade prostatic intraepithelial neoplasia alone. , 2001, Urology.

[44]  T. H. van der Kwast,et al.  Histopathological prostate cancer characteristics at radical prostatectomy after population based screening. , 2000, The Journal of urology.

[45]  R W Veltri,et al.  Analysis of repeated biopsy results within 1 year after a noncancer diagnosis. , 2000, Urology.

[46]  P. Troncoso,et al.  Strategy for repeat biopsy in patients with high grade prostatic intraepithelial neoplasia. , 2000, The Journal of urology.

[47]  J. Epstein,et al.  Foamy gland high-grade prostatic intraepithelial neoplasia. , 2000, The American journal of surgical pathology.

[48]  W. Sakr.  High-grade prostatic intraepithelial neoplasia: additional links to a potentially more aggressive prostate cancer? , 1998, Journal of the National Cancer Institute.

[49]  P. Humphrey,et al.  Unusual histologic types of high-grade prostatic intraepithelial neoplasia. , 1997, The American journal of surgical pathology.

[50]  A. Sagalowsky,et al.  Risk of concurrent prostate cancer in cystoprostatectomy specimens is related to volume of high-grade prostatic intraepithelial neoplasia. , 1997, Urology.

[51]  D. Bostwick,et al.  The extent and multicentricity of high-grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma. , 1997, Human pathology.

[52]  D. Bostwick,et al.  Prostatic intraepithelial neoplasia does not appear to raise serum prostate-specific antigen concentration. , 1996, Urology.

[53]  D. Bostwick,et al.  The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies. , 1995, The Journal of urology.

[54]  D. Grignon,et al.  EPIDEMOLOGY OF HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA , 1995 .

[55]  N. Pavletić,et al.  Neoplastic and borderline lesions of the prostate: autopsy study and epidemiological data. , 1995, Pathology, research and practice.

[56]  P. Humphrey,et al.  Morphometric analysis and clinical followup of isolated prostatic intraepithelial neoplasia in needle biopsy of the prostate. , 1995, The Journal of urology.

[57]  D. Grignon,et al.  Interobserver Reproducibility in the Diagnosis of Prostatic Intraepithelial Neoplasia , 1995, The American journal of surgical pathology.

[58]  J. Epstein,et al.  Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy. , 1993, Human pathology.

[59]  D. Bostwick,et al.  Architectural patterns of high-grade prostatic intraepithelial neoplasia. , 1993, Human pathology.

[60]  P. Lange,et al.  Significance of prostatic intraepithelial neoplasia on prostate needle biopsy. , 1991, Urology.

[61]  D. Grignon,et al.  Prostatic intraepithelial neoplasia and invasive prostatic adenocarcinoma in cystoprostatectomy specimens. , 1989, Urology.

[62]  R. Bahnson,et al.  Cytological atypia in the prostate gland: frequency, distribution and possible relevance to carcinoma. , 1986, The Journal of urology.

[63]  D. Bostwick,et al.  Intraductal dysplasia: a premalignant lesion of the prostate. , 1986, Human pathology.